Skip to main content

Table 2 Comparison of clinical characteristics according to the severity of TR in patients

From: The occurrence and risk factors of bradycardia after the Maze procedure in patients with atrial fibrillation and tricuspid regurgitation

Characteristics

Mild TR group (n = 50)

Moderate-to-severe TR group (n = 32)

P value

Age, y

58 (49–63)

58 (53–63)

0.875

Men, n (%)

16 (32)

8 (25)

0.497

Smoker, n (%)

9 (15)

6 (19)

0.932

Drinker, n (%)

3 (6)

0 (0)

0.875

Body mass index, kg/m2

24.00 ± 3.26

24.02 ± 3.59

0.985

Hypertension, n (%)

5 (10)

5 (16)

0.448

Diabetes, n (%)

2 (4)

2 (6)

0.645

ALT (U/L)

24.55 (17.5–44.2)

21.6 (13.5–32.25)

0.714

AST (U/L)

26 (20.25–30.75)

22 (18.05–30.725)

0.757

Total bilirubin (μmol/L)

15.6 (10.75–24.05)

18.2 (13.1–25.1)

0.063

Partial pressure of oxygen (mmHg)

85.65 (74.35–95.7)

85.8 (78.68–94.5)

0.827

Pro-BNP (ng/ml)

1452.5 (757.7–2594.26)

1314 (648.65–247.75)

0.112

LV ejection fraction (%)

60 (55–64)

58 (54–62)

0.682

Pulmonary systolic blood pressure (mmHg)

35.76 ± 9.04

41.75 ± 12.39

0.013

LV end-diastolic dimension (mm)

50.5 (47–53.25)

51.5 (47.75–56)

0.742

RV diameter (mm)

16 (15–18)

16 (15–18)

0.137

RV outflow tract diameter (mm)

26 (24–28)

27 (24–28)

0.935

AF duration time (years)

1.5 (0.2–6.5)

0.75 (0.14–2)

0.410

Preoperative heart rate

98 (79–114)

84 (71–102)

0.518

Euroscore II (%)

1.06 ± 0.36

1.13 ± 0.47

0.097

  1. Data were expressed as mean ± SD unless otherwise indicated
  2. TR tricuspid regurgitation, ALT alanine aminotransferase, AST aspartate aminotransferase, Pro-BNP, LV left ventricular, RV right valve, AF atrial fibrillation